Complaint alleging securities fraud in Martin Schiffenbauer v. Myovant Sciences Ltd., described as a Bermuda “pharmaceutical company” based in London, England; Terrie Curran, Mark Guinan, Adele M. Gulfo, Dave Marek, Shigeyuki Nishinaka, Myrtle Potter, and Nancy Valente at the U.S. District Court for the Southern District of New York.
17
December 11, 2022
Myovant Sciences Ltd., Terrie Curran, Mark Guinan, Adele M. Gulfo, Dave Marek, Shigeyuki Nishinaka, Myrtle Potter, Nancy Valente
Martin Schiffenbauer
Topics
Bermuda England Fraud Investment Listed SecuritiesKeywords
Adele Gulfo Dave Marek Mark Guinan Myovant Sciences Myrtle Potter